glp 1 gut microbiota Crosstalk between glucagon-like peptide and in metabolic diseases Interplay of gut microbiota, glucagon-like

These effects result directly from the medication's mechanism of actionspecifically, delayed gastric emptying and effects on gastrointestinal motility

The FDA had temporarily allowed compounded GLP-1s to be prescribed in 2022 due to a shortage of the drugs

Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients

Both Drucker and Nauck expect this trend will continue, with the drugs eventually used to help control cardiovascular risk in people without either diabetes or obesity

Multidisciplinary teams: Involve pharmacists, educators, and care navigators to reduce burden and improve patient support

Ask your doctor about the apps or trackers they recommend.